Large Granular Lymphocytosis in a Patient Infected with HTLV-II

AIDS Research and Human Retroviruses

Volumn 9, Issue 8, 1993, Pages 715-719

  Martin, Maureen P ^a   Biggar, Robert J ^b   Hamlin Green, Gina ^a,c   Staal, Stephen ^d   Mann, Dean ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c KAISER PERMANENTE   (United States)

^d Kaiser Permanente Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CELL POPULATION; CELL SELECTION; DNA DETERMINATION; FLOW CYTOMETRY; GENE AMPLIFICATION; HAIRY CELL LEUKEMIA; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOPHENOTYPING; LARGE GRANULAR LYMPHOCYTE; LYMPHOCYTOSIS; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; UNITED STATES;

ANTIGENS, CD; CASE REPORT; DNA, VIRAL; FLOW CYTOMETRY; GENES, POL; GENES, PX; HTLV-II INFECTIONS; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 2; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC; LYMPHOCYTOSIS; MALE; MIDDLE AGE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027255533     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1993.9.715     Document Type: Article

References (28)

1. Wong-Staal F. and Gallo RC.: Human T-lymphotropic retroviruses. Nature (London) 1985; 317: 395–403.
2. Blattner WA.: Retroviruses. In: Viral Infections of Humans, 3rd ed. Evans AS (Ed.). Plenum Medical Book Co., New York, 1989, pp. 545–592.
3. Maloney EM., Biggar RJ., Neel JV., Taylor ME., Hahn BH., Shaw GM., and Blattner WA.: Endemic human cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992; 166: 100–107.
4. Ehrlich GD., Glaser JB., LaVigne K., Quan D., Mildvan D., Sninsky JJ., Kwok S., Papsidero L., and Poiesz BJ.: Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. Blood 1989; 4: 1658–1664.
5. Yoshida M., Myoshi I., and Hinuma Y.: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Nati Acad Sci USA 1982; 79: 2031–2035.
6. Mann DL., DeSantis P., Mark G., Pfeifer A., Newman M., Gibbs N., Popovic M., Sarngadharan MG., Gallo RC., Clark J., and Blattner W.: HTLV-I associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science 1987; 236: 1103–1106.
7. Gessain A., Barin F., Vernant JC. Gout O., Maurs L., Calender A., and de The G.: Antibodies to the human lymphotropic virus type I in patients with tropical spastic parapareisis. Lancet 1985; 2: 407–410.
8. Osarne M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., and Tara H.: HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031–1032.
9. Kalyanaraman VS., Sarngadharan MG., Robert-Guroff M., Miyoshi I., Blayney D., Golde D., and Gallo RC.: A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218: 571–573.
10. Rosenblatt JD., Golde DW., Wachsman W., Giorgi JV., Jacobs A., Schmidt GM., Quan S., Gasson JC., and Chen ISY.: A second isolate of HTLV-II associated with atypical hairy cell leukemia. Engl J Med 1986; 315: 372–377.
11. Rosenblatt JD., Giorgi JV., Golde DW., Ezra JB., Wu A., Winberg CD., Glaspy J., Wachsman W., and Chen ISY.: Integrated human T-cell leukemia virus II genome in CD8 + cells from a patient with “atypical” hairy cell leukemia: evidence for distinct and cell lymphoproliferative disorders. Blood 1988; 71: 363–369.
12. Sohn CC., Blayney DW., Misset JL., Mathe G., Flandrin G., Moran EM., Jensen FC., Winberg CD., and Rappaport H.: Leukopenic chronic cell leukemia mimicking hairy-cell leukemia: association with human retroviruses. Blood 1986; 67: 949–956.
13. Starkebaum G., Loughran TP. Jr, Kalyanaraman VS., Kadin ME., Kidd PG., Singer JW., and Ruscetti FW.: Serum reactivity to HTLV-1 proteins in patients with LGL leukemia. Lancet 1987; 1: 596–599.
14. Pandolfi F., Shriver K., Scarselli E., Fiorelli V., Semenzato G., Zambello R., Chisesi T., de Rossi G., and Strong DM.: HTLV-I antibodies and lymphoproliferative disease of granular lymphocytes. Lancet 1987; 2: 1527.
15. Loughran TP. Jr, Coyle C., Sherman MP., Starkebaum G., Ehrlich GD., Ruscetti FW., and Poiesz BJ.: Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocytic leukemia. Blood 1992; 80: 1116–1119.
16. Kwok S., Ehrlich G., Poiesz B., Kalish R., and Sninsky JJ.: Enzymatic amplification of HTLV-1 viral sequences from peripheral blood mononuclear cells and infected tissues. Blood 1988; 72: 1117–1123.
17. De BK. and Srinivasan A.: Detection of human immunodeficiency virus (HIV) and human lymphotropic virus (HTLV) type I or II dual infections by polymerase chain reaction. Oncogene 1989; 4: 1533–1535.
18. Chorba TL., Brynes R., Kalyanaraman VS., Telfer M., Ramsey R., Mawle A., Palmer EL., Chen ATL., Feorino P., and Evatt BL.: Transformed lymphocytes infected by a novel isolate of human cell leukemia virus type II. Blood 1985; 66: 1336–1342.
19. Shimotohno K., Takahashi Y., Shimizu N., Gojobori T., Golde DW., Chen ISY., Miwa M., and Sugimura T.: Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Nati Acad Sci USA 1985; 82: 3101–3105.
20. Ijichi S., Ramundo MB., Takahashi H., and Hall WW.: In vivo cellular tropism of human cell leukemia virus type II (HTLV-II). J Exp Med 1992; 176: 293–296.
21. Chan WC., Link S., Mawle A., Check I., Bryness RK., and Winton EF.: Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes. Blood 1986; 68: 1142–1153.
22. Chan WC., Gu LB., Masih A., Nicholson J., Vogler WR., Yu G., and Nasr S.: Large granular lymphocyte proliferation with the natural killer-cell phenotype. Am J Clin Pathol 1992; 97: 353–358.
23. Popovic M., Flomenberg N., Volkman DJ., Mann D., Fauci AS., Dupont B., and Gallo RC.: Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science 1984; 226: 459–462.
24. Greene WC., Leonard WL., Wano Y., Svetlik PB., Peffer NJ., Sodroski JG., Rosen CA., Goh WC., and Haseltine WA.: Transactivator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression. Science 1986; 232: 877–880.
25. Lai RB. and Rudolph DL.: Constitutive production of interleukin-6 and tumor necrosis factor- from spontaneously proliferating cells in patients with human T-cell lymphotropic virus type-I/II. Blood 1991; 78: 571–574.
26. Chehimi J., Starr SE., Frank I., Rengaraju M., Jackson SJ., Lianes C., Kobayashi M., Perussia B., Young D., Nickbarg E., Wolf SF., and Trinchieri G.: Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 1992; 175: 789–796.
27. Wolf S., Seiburth D., Perussia B., Yetz-Adalpe J., D'Andrea A., and Trinchieri G.: Cell sources of natural killer cell stimulatory factor (NKSF/IL-12) transcripts and subunit expression. FASEB J 1992; 6: A1335.
28. Chen ISY., Quan SG., and Golde DW.: HTLV-II transforms normal human lymphocytes. Proc Nati Acad Sci USA 1983; 80: 7006–7009.